Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies.
Girmenia
C
C
Martino
P
P
Cassone
A
A
D002175:Candida / Q000145:classification / Q000187:drug effects*; D002177:Candidiasis / Q000382:microbiology* / Q000517:prevention & control; D002405:Catheterization, Central Venous / Q000009:adverse effects; D004198:Disease Susceptibility; D004352:Drug Resistance, Microbial; D015725:Fluconazole / Q000494:pharmacology* / Q000627:therapeutic use; D016469:Fungemia / Q000382:microbiology* / Q000517:prevention & control; D006801:Humans; D007938:Leukemia / Q000150:complications*; D008223:Lymphoma / Q000150:complications*; D013045:Species Specificity; D017211:Treatment Failure
D015725:Fluconazole